Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof

US8404709B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Santiago Figueroa Perez · Leverkusen, DE
• Peter Kolkhof · Wuppertal, DE
• Lars Bärfacker · Oberhausen, DE
• Ingo Flamme · Bergneustadt, DE
• Karl-Heinz Schlemmer · Wuppertal, DE
• Rolf Grosser · Schwandorf, DE
• Klaus Münter · Mannheim, DE
• Andreas Knorr · Erkrath, DE
• Adam Nitsche · Pulheim, DE

Key dates

• Filing date: Jun 1, 2007
• Grant date: Mar 26, 2013
• Expiry date: Dec 6, 2028

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P13/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridines, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.